Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Rashmi Kumari

Is Edwards Lifesciences Stock Underperforming the S&P 500?

Edwards Lifesciences Corporation (EW), a global leader in patient-focused medical innovations, was founded in 1958 and is headquartered in Irvine, California. With a market cap of $42.2 billion, Edwards Lifesciences is a key player in the healthcare industry, specializing in cutting-edge technologies for structural heart disease and critical care monitoring. 

Companies with a market value of $10 billion or more are classified as “large-cap stocks,” Edwards Lifesciences firmly belongs in this category. With a strong track record of financial performance and a commitment to advancing medical technology, Edwards excels in specialized healthcare sectors, including structural heart innovations and critical care solutions. Its innovative products and patient-focused approach drive significant impact across global healthcare markets.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.